2,3-bis(3'-hydroxybenzyl)butyrolactone and Experimental Hepatoma

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Miura, D; Miura, Y; Saarinen, NM; Santti, R; Yagasaki, K	1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Experimental Hepatoma

Article	Year
Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats. Nutrition and cancer, 2007, Volume: 58, Issue:1 Topics: 4-Butyrolactone; Animals; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lignans; Liver Neoplasms, Experimental; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Tumor Cells, Cultured	2007

Article

Year

Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats.

Nutrition and cancer, 2007, Volume: 58, Issue:1

Topics: 4-Butyrolactone; Animals; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lignans; Liver Neoplasms, Experimental; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Tumor Cells, Cultured

2007